[1] |
WEN Ziqiang, LAN Junliang, ZHOU Bo, XU Qiwei.
PARP1 promotes the progression of hepatocellular carcinoma by regulating expression of POU2F2
[J]. China Oncology, 2024, 34(9): 848-856.
|
[2] |
WU Wen, ZHANG Ruoxin, WENG Junyong, MA Yanlei, CAI Guoxiang, LI Xinxiang, YANG Yongzhi.
Exploring the prognostic value of positive lymph node ratio in stage Ⅲ colorectal cancer patients and establishing a predictive model
[J]. China Oncology, 2024, 34(9): 873-880.
|
[3] |
XIAO Feng, XU Tonglin, ZHU Lin, XIAO Jingwen, WU Tianqi, GU Chunyan.
Significance of infiltration of M1 tumor-associated macrophages in hepatocellular carcinoma
[J]. China Oncology, 2024, 34(8): 726-733.
|
[4] |
CAO Fei, YU Wenhao, TANG Xiaonan, MA Zidong, CHANG Tingmin, GONG Yabin, LIAO Mingjuan, KANG Xiaohong.
Mechanism of LINC01410 promoting proliferation and migration in esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(8): 753-762.
|
[5] |
CHEN Xun, ZHENG Zhenxia, RUAN Xueru.
Effects of TMCO1 on proliferation and migration of cervical cancer cells
[J]. China Oncology, 2024, 34(6): 571-580.
|
[6] |
SUN Rongqi, SONG Ning, ZHENG Wentian, ZHANG Xinyue, LI Minmin, GONG Hui, JIANG Yingying.
Effect of long noncoding RNA FLJ30679 on proliferation and migration of oral squamous cell carcinoma cells
[J]. China Oncology, 2024, 34(5): 439-450.
|
[7] |
XIONG Jiayan, LEI Wei, YOU Bo, ZHANG Zhenxin, XIE Haijing, SHAN Ying, XIA Tian, ZHOU Yong.
Study on the mechanism of DDX6 promoting proliferation and migration of nasopharyngeal carcinoma cells by regulating stability of CKMT1A mRNA
[J]. China Oncology, 2024, 34(5): 451-459.
|
[8] |
ZHOU Xueqin, LUAN Yanchao, ZHAO Li, RONG Chaochao, YANG Na.
Expression of CDC20 in lung adenocarcinoma tissues and its effect on the proliferation and invasion of lung adenocarcinoma cells
[J]. China Oncology, 2024, 34(5): 460-472.
|
[9] |
GUAN Ruirui, HAO Qian, ZHANG Yaqi, SUN Qinggang, CHEN Yitian, LI Xiumin, ZHOU Xiang, HAN Tao.
CDC20 facilitates the proliferation of esophageal carcinoma cell by stabilizing NLRP3 expression
[J]. China Oncology, 2024, 34(5): 473-484.
|
[10] |
ZHANG Ruoxin, YE Zilan, WENG Junyong, LI Xinxiang.
Correlation study between advanced age and inferior prognosis in stage Ⅱ colorectal cancer patients
[J]. China Oncology, 2024, 34(5): 485-492.
|
[11] |
LI Jun, LU Tingwei, FANG Xuqian.
Impact of MSI-H/dMMR on clinicopathological characteristics and prognosis of patients with BRAF V600E-mutated resectable colorectal cancer
[J]. China Oncology, 2024, 34(11): 1061-1066.
|
[12] |
WU Zhibai, XU Guiqin, ZHANG Li, YANG Zhaojuan, LIU Yun, JIAO Kun, CHEN Zehong, XU Chen, ZUO You, ZHENG Ningqian, YE Zhiqian, LIU Yongzhong.
Mechanism study of KCMF1 promoting proliferation and NF-κB signaling transduction in colorectal cancer cells
[J]. China Oncology, 2024, 34(11): 987-997.
|
[13] |
JIN Yizi, LIN Mingxi, ZHANG Jian.
Receptor discordance between primary breast cancer and liver metastases
[J]. China Oncology, 2023, 33(9): 834-843.
|
[14] |
WU Han, YANG Zhangru, FENG Wen, ZENG Wanqin, GUO Jindong, LI Hongxuan, WANG Changlu, WANG Jiaming, LÜ Changxing, ZHANG Qin, YU Wen, CAI Xuwei, FU Xiaolong.
The efficacy and prognosis analysis after stereotactic body radiotherapy for multiple primary early-stage lung cancer
[J]. China Oncology, 2023, 33(9): 844-856.
|
[15] |
CHEN Jinjuan, WANG Xingran, LI Wenzhi, CHENG Yu, SUN Yihua, TAO Xiang, MA Fenghua, SUN Li, ZHAO Hongbo, LU Xin.
Conservative surgery in stage I placental site trophoblastic tumor: a report of 10 cases and literature review
[J]. China Oncology, 2023, 33(9): 857-865.
|